CHURCHILL MANAGEMENT Corp Sells 609 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

CHURCHILL MANAGEMENT Corp trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,091 shares of the financial services provider’s stock after selling 609 shares during the period. CHURCHILL MANAGEMENT Corp’s holdings in iShares Biotechnology ETF were worth $1,110,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of IBB. Crewe Advisors LLC raised its stake in iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after buying an additional 78 shares in the last quarter. Apexium Financial LP raised its stake in iShares Biotechnology ETF by 3.8% in the fourth quarter. Apexium Financial LP now owns 2,223 shares of the financial services provider’s stock worth $302,000 after buying an additional 82 shares in the last quarter. Jacobi Capital Management LLC grew its holdings in iShares Biotechnology ETF by 3.7% in the third quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock worth $310,000 after purchasing an additional 91 shares during the period. HB Wealth Management LLC grew its holdings in iShares Biotechnology ETF by 5.9% in the fourth quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock worth $257,000 after purchasing an additional 105 shares during the period. Finally, Peterson Wealth Management grew its holdings in iShares Biotechnology ETF by 2.9% in the third quarter. Peterson Wealth Management now owns 3,743 shares of the financial services provider’s stock worth $458,000 after purchasing an additional 106 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $137.34 on Friday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The firm’s 50-day simple moving average is $133.17 and its two-hundred day simple moving average is $134.40.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.